SMS Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: SMSPHARMA | BSE: 532815
₹212.35 
8.70 (4.27 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 222.00
High (₹) 224.60
Low (₹) 204.50
Prev. Close (₹) 203.65
Volume 29,867
VWAP (₹) 215.68
ROCE (%) 12.75
Industry P/E 43.99
TTM P/E 27.19
P/B Ratio 3.39
Market Cap (₹) Cr.1,815.62
Dividend Yield (%)0.19
EPS (₹) 5.89
ROE9.30%
Sales Growth (%) 35.86
Profit Growth (%)1,166.7
Day Range
224.60224.60
52 Week Range
140.20398.00
Historical Returns
Returns (6M)
-37.49 %
Returns (1Y)
49.7 %
Returns (3Y)
106.57 %
Returns (5Y)
462.52 %
Returns (6M)
-37.49 %
Returns (1Y)
49.7 %
Returns (3Y)
106.57 %
Returns (5Y)
462.52 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- High CCI indicates strong upward momentum.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 49.99
MFI 55.74
ATR 13.18
Commodity Channel Index 111.71
ROC125 -39.89
ROC21 4.59
Williams %R -23.86
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 224.46 | 234.58 | 244.56 | 214.48 | 204.36 | 194.38 | 184.26 |
| Week Ago | 206.39 | 214.12 | 219.19 | 201.32 | 193.59 | 188.52 | 180.79 |
| Month Ago | 223.61 | 229.73 | 233.11 | 220.23 | 214.11 | 210.73 | 204.61 |
EMA & SMA
212.35
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
6
5 Day 195.99
9 Day 200.30
10 Day 203.26
12 Day 205.69
14 Day 204.67
20 Day 201.94
26 Day 206.37
50 Day 221.93
100 Day 259.71
200 Day 263.24
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 30 Mar, 2024 | Neelima Potluru | Disposal | ₹182.2649336870026525198938992 | 18,850 | BSE |
| 29 Mar, 2024 | P Seeta Rama Brahmam | Disposal | ₹182.8650668151447661469933185 | 89,800 | BSE |
| 29 Mar, 2024 | TVT INFRACON LLP | Acquisition | ₹183.5385375 | 80,000 | BSE |
| 29 Mar, 2024 | Hima Bindu Potluri | Acquisition | ₹184.3088090909090909090909091 | 2,20,000 | BSE |
| 20 Mar, 2024 | Vamsi Krishna Potluri | Acquisition | ₹31.75 | 25,00,000 | BSE |
| 20 Mar, 2024 | Trolik Potluri | Acquisition | ₹31.75 | 25,00,000 | BSE |
| 20 Mar, 2024 | Ramesh Babu Potluri | Acquisition | ₹31.75 | 25,00,000 | BSE |
| 20 Mar, 2024 | POTLURI INFRA PROJECTS LLP | Acquisition | ₹31.75 | 15,00,000 | BSE |
| 19 Dec, 2023 | Vamsi Krishna Potluri | Revoke | ₹118.35 | 7,68,000 | BSE |
| 14 Dec, 2023 | Vamsi Krishna Potluri | Revoke | ₹118.90 | 12,62,590 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 May, 2024 | Rs.0.4000 per share(40%)Final Dividend | 23 Sept, 2024 | 23 Sept, 2024 |
| 24 May, 2023 | Rs.0.3000 per share(30%)Final Dividend | 22 Sept, 2023 | 22 Sept, 2023 |
| 30 May, 2022 | Rs.0.3000 per share(30%)Final Dividend | 22 Sept, 2022 | 23 Sept, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 14 Feb, 2025 | NSE India | SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
| 12 Feb, 2025 | NSE India | Integrated Financials |
| 12 Feb, 2025 | NSE India | Integrated Financials |
| 12 Feb, 2025 | BSE India | Investor Presentation on Financial Results |
| 12 Feb, 2025 | NSE India | SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation |
| 12 Feb, 2025 | BSE India | Press Release on Financial Results |
| 12 Feb, 2025 | NSE India | SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 12, 2025, titled ""Press release on Financial Results"". |
| 12 Feb, 2025 | BSE India | Monitoring Agency Report for the Quarter ended 31st December, 2024 |
| 12 Feb, 2025 | NSE India | Monitoring Agency Report for the quarter ended 31st December, 2024 |
| 12 Feb, 2025 | BSE India | Intimation of Determination of materiality |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 07 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 08 Nov, 2024 |
| Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
| Audited Results & Final Dividend | -- | 23 May, 2024 | 29 May, 2024 |
| Quarterly Results & Preferential issue | -- | 07 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results & Final Dividend | -- | 18 May, 2023 | 24 May, 2023 |
| Quarterly Results | -- | 01 Feb, 2023 | 09 Feb, 2023 |
| Quarterly Results | -- | 09 Nov, 2022 | 12 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About SMS Pharmaceuticals
SMS Pharmaceuticals is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 709.26 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1987
Managing Director
Mr. Ramesh Babu Potluri
NSE Symbol
SMSPHARMA
SMS Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ramesh Babu Potluri | Chairman & Managing Director |
| Mr. Vamsi Krishna Potluri | Executive Director |
| Mr. Sarath Kumar Pakalapati | Independent Director |
| Mr. Sharvan Kudaravalli | Independent Director |
| Mr. Sarvepalli Srinivas | Independent Director |
| Dr.(Mrs.) Neelaveni Thummala | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on SMS Pharmaceuticals
What is the share price of SMS Pharmaceuticals?
The share price of SMS Pharmaceuticals on 21 Feb, 2025 is ₹ 212.35.
What is 52W high and 52W low share price of SMS Pharmaceuticals?
The highest and lowest 52W share prices of SMS Pharmaceuticals are ₹ 398.000 and ₹ 118.600
What is the market cap of SMS Pharmaceuticals?
The market capitalization of SMS Pharmaceuticals as of 21 Feb, 2025 is ₹ 1,815.62 Crores
What is the P/E ratio of SMS Pharmaceuticals?
The current P/E ratio of SMS Pharmaceuticals as of 21 Feb, 2025 is 43.99
What is the PB ratio of SMS Pharmaceuticals?
The PB ratio of SMS Pharmaceuticals as of 21 Feb, 2025 is 3.39
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)